[Impairment of intestinal glucose absorption by biguanide derivatives].
D000367:Age Factors; D000818:Animals; D001645:Biguanides / Q000494:pharmacology* / Q000627:therapeutic use; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000188:drug therapy*; D004285:Dogs; D005947:Glucose / Q000008:administration & dosage / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006801:Humans; D007263:Infusions, Parenteral; D007408:Intestinal Absorption / Q000187:drug effects*; D007421:Intestine, Small / Q000187:drug effects; D010477:Perfusion; D010629:Phenformin / Q000494:pharmacology
D001645:Biguanides; D001786:Blood Glucose; D010629:Phenformin; D005947:Glucose